Michael Krautkramer
COO Next Generation Therapeutics @ Eli Lilly and Company
About Michael Krautkramer
Michael Krautkramer serves as the COO of Next Generation Therapeutics at Eli Lilly and Company, a position he has held since 2020. He has extensive experience in the healthcare industry, having worked in various roles at companies such as Boston Scientific and Avid Radiopharmaceuticals.